Heartland Bank & Trust Co Decreases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Heartland Bank & Trust Co lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 15.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,836 shares of the medical equipment provider’s stock after selling 326 shares during the quarter. Heartland Bank & Trust Co’s holdings in Intuitive Surgical were worth $958,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Massachusetts Financial Services Co. MA purchased a new stake in Intuitive Surgical during the 3rd quarter worth about $558,807,000. International Assets Investment Management LLC grew its holdings in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after buying an additional 1,088,415 shares in the last quarter. FMR LLC raised its position in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the last quarter. Wilmington Savings Fund Society FSB lifted its stake in shares of Intuitive Surgical by 15,322.2% during the third quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Finally, State Street Corp boosted its position in Intuitive Surgical by 1.4% during the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after acquiring an additional 210,363 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 376 shares of the business’s stock in a transaction that occurred on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 42,453 shares of company stock worth $22,059,506. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Stock Down 4.0 %

ISRG stock opened at $584.05 on Monday. The business has a fifty day moving average of $547.16 and a 200-day moving average of $505.21. The company has a market cap of $208.03 billion, a P/E ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. Royal Bank of Canada raised their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Truist Financial raised their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research note on Friday. BTIG Research increased their price objective on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. One research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $583.83.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.